510(k) device
OPTIMUM GP (roflufocon D, roflurocon E) Daily Wear Contact Lens
Contamac, Ltd. · Lens, Contact (Other Material) - Daily (HQD, Class II) · First FDA decision Mar 19, 2004, newest Apr 25, 2018Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
3
Naming "OPTIMUM GP"
MAUDE reports
0
Brand "OPTIMUM GP", since 2015
PubMed studies
0
Mentioning "OPTIMUM GP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OPTIMUM GP (roflufocon D, roflurocon E) Daily Wear Contact Lens
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K180616 · Decided Apr 25, 2018 · 48 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
K161100 · Decided Aug 10, 2016 · 113 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
K070628 · Decided May 1, 2007 · 55 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "OPTIMUM GP", any status and sponsor, newest update first.
- The COPD OptimiserCompleted
General Practitioners Research InstituteResearch network
NCT06659666 · 100 participants · Start Oct 9, 2024 · Primary completion Jan 20, 2025
Device: COPD Optimiser · For: COPD
Sites: Groningen, Netherlands · 2 sites in all
- Optimizing PharmacoTherapy In the Multimorbid Elderly in Primary CAre: the OPTICA TrialPivotal-lookingCompleted
University of BernAcademic, hospital or other
NCT03724539 · 323 participants · Start Jan 7, 2019 · Primary completion Feb 15, 2021
Device: STRIPA intervention · For: Multimorbidity; Polypharmacy
Sites: Bern, Switzerland
Yonsei UniversityAcademic, hospital or other
NCT01679262 · 149 participants · Start May 2010 · Primary completion May 2012
Device: Guedel type color-coded OPAs · For: Ear,Nose and Throat Surgery
Sites: Seoul, South Korea
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OPTIMUM GP", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HQD
37 reports: 3 malfunction, 34 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2981-2018 · Started Jul 3, 2018
Reason given: Vials labeled for the prescriptions contained incorrect lenses
Cause as FDA categorized it: Process control · Device type: Lens, Contact (Other Material) - Daily (HQD)
Z-2982-2018 · Started Jul 3, 2018
Reason given: Vials labeled for the prescriptions contained incorrect lenses
Cause as FDA categorized it: Process control · Device type: Lens, Contact (Other Material) - Daily (HQD)
Published research
The most relevant PubMed records for "OPTIMUM GP"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HQD.
- Menicon Sf-P (Tm)Menicon Co, Ltd. · PMA 2000
- Synergeyes Hybrid Contact Lenses - Daily Wear, Models A, M, Kc and PsSynergeyes, Inc. · 510(k) 2008
- Rigid Gas Permeable Contact Lens SolutionPolymer Technology Corp. · 510(k) 2001
- Acuity 200 (fluoroxyfocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2024
- Visionary Optics Scleral Contact Lens (roflufocon D, roflufocon E, hexafocon A, hexafocon B, tisilfocon A, fluoroxyfocon A)Visionary Optics, LLC · 510(k) 2024
- Custom Stable Rigid Gas Permeable Scleral Contact LensValley Contax, Inc. · 510(k) 2022
- Acuity 18 (enflufocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2018
- FluoroPerm 30 & Paragon Thin (paflufocon C) RGP contact lenses with Tangible Hydra-PEGParagon Vision Sciences · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.